These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3372029)

  • 41. Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.
    Papich MG
    J Vet Intern Med; 2017 Sep; 31(5):1508-1513. PubMed ID: 28771831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of ciprofloxacin in hospitalized geriatric patients: comparison between nasogastric tube and oral administration.
    Lubart E; Berkovitch M; Leibovitz A; Britzi M; Soback S; Bukasov Y; Segal R
    Ther Drug Monit; 2013 Oct; 35(5):653-6. PubMed ID: 23942542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enteric absorption of ciprofloxacin during tube feeding in the critically ill.
    Cohn SM; Sawyer MD; Burns GA; Tolomeo C; Milner KA
    J Antimicrob Chemother; 1996 Nov; 38(5):871-6. PubMed ID: 8961058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung tissue concentrations of ciprofloxacin following intravenous administration in patients.
    Forst H; Ruckdeschel G; Unertl K; Dieterich HJ; Ehret W; Sunder-Plassmann L
    Arzneimittelforschung; 1989 May; 39(5):618-9. PubMed ID: 2757681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibacterial efficacy and pharmacokinetic studies of ciprofloxacin on Pasteurella multocida infected rabbits.
    Hanan MS; Riad EM; el-Khouly NA
    Dtsch Tierarztl Wochenschr; 2000 Apr; 107(4):151-5. PubMed ID: 10829566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg po twice daily.
    Shah A; Lettieri J; Kaiser L; Echols R; Heller AH
    J Antimicrob Chemother; 1994 Apr; 33(4):795-801. PubMed ID: 8056698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Penetration of ciprofloxacin in bronchial secretions after intravenous administration.
    Berré J; Thys JP; Husson M; Gangji D; Klastersky J
    J Antimicrob Chemother; 1988 Oct; 22(4):499-504. PubMed ID: 3204076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetration of cefotetan into serum, myometrium, endometrium and salpinges.
    Just HM; Petersen EE; Bassler M; Frank U; Daschner FD
    Chemotherapy; 1984; 30(5):305-7. PubMed ID: 6593163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
    Schuck EL; Dalhoff A; Stass H; Derendorf H
    Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasopressin and oxytocin receptors in vagina, myometrium, and oviduct of rabbits.
    Maggi M; Genazzani AD; Giannini S; Torrisi C; Baldi E; di Tomaso M; Munson PJ; Rodbard D; Serio M
    Endocrinology; 1988 Jun; 122(6):2970-80. PubMed ID: 2836178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetics of ciprofloxacin injection in healthy volunteers].
    Hong Z; Wang Y; Xu N; Zhang H; Liang D
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):315-8. PubMed ID: 8586400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg.
    Szałek E; Tomczak H; Kamińska A; Grabowski T; Smuszkiewicz P; Matysiak K; Wolc A; Kaczmarek Z; Grześkowiak E
    Adv Med Sci; 2012; 57(2):217-23. PubMed ID: 22968336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tissue distribution of cefotetan in the field of obstetrics and gynecology].
    Nishino H; Nagamatsu M; Ishii S; Takamatsu S; Saito J; Yamanaka K
    Jpn J Antibiot; 1983 Feb; 36(2):398-407. PubMed ID: 6574265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges.
    Nau R; Prange HW; Martell J; Sharifi S; Kolenda H; Bircher J
    J Antimicrob Chemother; 1990 Jun; 25(6):965-73. PubMed ID: 2370242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of chloroquine on the bioavailability of ciprofloxacin in humans.
    Ilo CE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo JC; Agbasi PU; Orisakwe OE
    Am J Ther; 2006; 13(5):432-5. PubMed ID: 16988539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progesterone receptor and regulation of progestin action in mammalian tissues.
    Jänne O; Kontula K; Vihko R; Feil PD; Bardin CW
    Med Biol; 1978 Oct; 56(5):225-48. PubMed ID: 362080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.